Explore the latest strategies in cardiovascular disease prevention in this live 3-part webinar CME series. Dr. Tokgozoglu will review dyslipidemia in the development of atherosclerosis and the utilization of atherosclerosis imaging to guide treatment decisions. Prof. Kausik will discuss the most recent evidence-based guidelines regarding ASCVD risk stratification and assess current and emerging therapies for lipid modification.
Dyslipidemia and atherosclerotic vascular disease: From biology to imaging | Lale Tokozoglu
Quantifying cardiovascular risk and guideline implementation-focus on lipids | Prof. Kausik K Ray
Current and emerging therapies for lipid modification | Prof. Kausik K Ray
Lale Tokgozoglu MD FACC FESC
Prof. Kausik K Ray